Abstract
Migraine is one of more than 200 headache disorders but stands out among these as a major cause of population ill health. In migraine epidemiology, the key variable is prevalence, but, from the perspective of public health, prevalence is uninformative without burden estimates. Here, we discuss how migraine epidemiology, from a quite recent start, has evolved into the respectable though imperfect science of today, but with the legacy that much of the large corpus of older literature is of questionable reliability. Newer studies have benefited from a universally accepted definition of migraine, while methodological developments have broadened the scope of migraine caseness, and published guidelines address important methodological issues. In the light of these developments, we question the apparent increase in migraine prevalence over time, offering explanations as to why this may be illusory. We suggest that the current best estimates are that global migraine prevalence is 14–15%, and that migraine accounts for 4.9% of global population ill health quantified in years lived with disability (YLDs). These evaluations are probably under-quantified rather than over-quantified, and YLDs are not a comprehensive measure of migraine-attributed burden. Despite these uncertainties, such high estimates of population ill health have clear implications for health policy.
Key points
-
Migraine is one of more than 200 recognized headache disorders but, as a major cause of global population ill health, stands out from all others in the context of public health.
-
Although prevalence is the key variable in migraine epidemiology, prevalence estimates, from the perspective of public health, are uninformative without associated burden estimates.
-
Migraine epidemiology is a young and evolving science, and, with an accepted definition of migraine available only since 1988, much in the large corpus of older literature is of questionable reliability.
-
Accordingly, the apparent increase in migraine prevalence over the past three decades may be illusory.
-
The current best estimate of global migraine prevalence is 14–15%, and, in terms of burden, migraine accounts for 4.9% of global ill health, quantified as years lived with disability.
-
These evaluations are still attended by uncertainty and are probably under-quantified rather than over-quantified.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders 3rd edition. Cephalalgia 38, 1–211 (2018). This and earlier versions of the classification provide operational diagnostic criteria and constitute the basis for migraine epidemiology, although they are primarily for clinical use.
Stovner, L. J. et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 954–976 (2018). The most detailed description of the methods for and results from the analysis of headache data in the Global Burden of Disease Study.
World Health Organization. Atlas of Headache Disorders and Resources in the World 2011 (WHO, 2011). A useful document from the WHO for those advocating for the allocation of more resources to headache care or research.
Steiner, T. J. et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J. Headache Pain. 21, 137 (2020).
Institute of Health Metrics and Evaluation. Global Burden of Disease Study 2019 is here! IHME https://mailchi.mp/healthdata/07022020-2871488?e=99a49e288b (2019).
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
Salomon, J. A. et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob. Health 3, e712–e723 (2015).
Grosse, S. D., Lollar, D. J., Campbell, V. A. & Chamie, M. Disability and disability-adjusted life years: not the same. Public Health Rep. 124, 197–202 (2009).
Murray, C. J. et al. GBD 2010: design, definitions, and metrics. Lancet 380, 2063–2066 (2012).
Steiner, T. J. et al. Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: expert consensus on definitions from a Delphi process. Cephalalgia 42, 1387–1396 (2022).
Lampl, C. et al. Interictal burden attributable to episodic headache: findings from the Eurolight project. J. Headache Pain. 17, 9 (2016).
Stovner, L. J. et al. The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J. Headache Pain. 15, 5 (2014). Guidelines for studies on headache prevalence, burden and cost, made under the auspices of Lifting The Burden, with representation from all WHO regions, aiming to improve the quality and comparability of future studies.
Steiner, T. J. et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J. Headache Pain. 15, 3 (2014). Presentation of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire, an instrument for data collection in headache prevalence and burden studies, with several modules that can be selected according to the scope and resources of a particular study.
Thomas, H. et al. The relationship between headache-attributed disability and lost productivity: 2. Empirical evidence from population-based studies in nine disparate countries. J. Headache Pain. 22, 153 (2021).
Leonardi, M. & Mathers, C. Global burden of migraine in the year 2000: summary of methods and data sources. Academia https://www.academia.edu/es/14204626 (2000). The first paper using GBD study methods to evaluate the burden of migraine worldwide, ranking it among the 20 most disabling disorders.
Vos, T. et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163–2196 (2012). The first paper with new and improved GBD study methods, ranking migraine as the seventh most disabling disorder globally.
Institute of Health Metrics and Evaluation (IHME). GBD Results https://vizhub.healthdata.org/gbd-results/ (2019).
Wober-Bingol, C. et al. The global burden of headache in children and adolescents – developing a questionnaire and methodology for a global study. J. Headache Pain. 15, 86 (2014).
Ziegler, D. K. Handbook of Clinical Neurology Vol. 48, Ch. 2 (eds Vinken, P. J., Bruyn, G. W., Klawans, H. L. & Rose, F. C.) 13–22 (Elsevier, 1986).
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7), 1–96 (1988).
Stovner, L. J., Hagen, K., Linde, M. & Steiner, T. J. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J. Headache Pain. 23, 34 (2022). A review updating Stovner et al. (2007)41, also aiming to understand the methodological factors that influence estimates of the prevalence of headache disorders.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 24 (Suppl. 1), 1–160 (2004).
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33, 629–808 (2013).
Adams, A. M. et al. The impact of chronic migraine: the Chronic Migraine Epidemiology and Outcomes (CaMEO) study methods and baseline results. Cephalalgia 35, 563–578 (2015).
Natoli, J. L. et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 30, 599–609 (2010). The first attempt to review the prevalence of chronic migraine.
Peters, G. A. & Horton, B. T. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc. Staff. Meet. Mayo Clin. 26, 153–161 (1951).
Silberstein, S. D. et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) – revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25, 460–465 (2005).
Steiner, T. J. Can we know the prevalence of MOH? Cephalalgia 34, 403–404 (2014).
World Health Organisation. ICD-11: International Classification of Diseases 11th Revision. WHO https://icd.who.int/en (2022).
Ayzenberg, I. et al. The burden of headache in Russia: validation of the diagnostic questionnaire in a population-based sample. Eur. J. Neurol. 18, 454–459 (2011).
Yu, S. Y. et al. The burden of headache in China: validation of diagnostic questionnaire for a population-based survey. J. Headache Pain. 12, 141–146 (2011).
Rao, G. N. et al. The burden of headache disorders in India: methodology and questionnaire validation for a community-based survey in Karnataka State. J. Headache Pain. 13, 543–550 (2012).
Steiner, T. J. et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23, 519–527 (2003).
Wober, C. et al. Undifferentiated headache: broadening the approach to headache in children and adolescents, with supporting evidence from a nationwide school-based cross-sectional survey in Turkey. J. Headache Pain. 19, 18 (2018). A paper highlighting problems in headache epidemiology and its classification among young people, introducing the term ‘undifferentiated headache’ as an immature expression of migraine or tension-type headache.
Philipp, J. et al. Prevalence and burden of headache in children and adolescents in Austria – a nationwide study in a representative sample of pupils aged 10–18 years. J. Headache Pain. 20, 101 (2019).
Genc, D. et al. The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study. J. Headache Pain. 21, 73 (2020).
Luvsannorov, O. et al. The prevalence of headache disorders in children and adolescents in Mongolia: a nationwide schools-based study. J. Headache Pain. 21, 107 (2020).
Zenebe Zewde, Y. et al. The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study. J. Headache Pain. 21, 108 (2020).
Togha, M. et al. The prevalence of headache disorders in children and adolescents in Iran: a schools-based study. Cephalalgia 42, 1246–1254 (2022).
Kawatu, N. et al. The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study. J. Headache Pain. 23, 118 (2022).
Stovner, L. J. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193–210 (2007). The first review of data on headache prevalence conducted by Lifting The Burden.
Woldeamanuel, Y. W. & Cowan, R. P. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J. Neurol. Sci. 372, 307–315 (2017). A systematic review indicating an increase in migraine prevalence over time.
Steiner, T. J. et al. The Global Campaign turns 18: a brief review of its activities and achievements. J. Headache Pain. 23, 49 (2022).
Ayzenberg, I. et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32, 373–381 (2012).
Yu, S. et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52, 582–591 (2012).
Kulkarni, G. B., Rao, G. N., Gururaj, G., Stovner, L. J. & Steiner, T. J. Headache disorders and public ill-health in India: prevalence estimates in Karnataka State. J. Headache Pain. 16, 67 (2015).
Herekar, A. D. et al. The burden of headache disorders in Pakistan: methodology of a population-based nationwide study, and questionnaire validation. J. Headache Pain. 14, 73 (2013).
Manandhar, K., Risal, A., Steiner, T. J., Holen, A. & Linde, M. The prevalence of primary headache disorders in Nepal: a nationwide population-based study. J. Headache Pain. 16, 95 (2015).
Mbewe, E. et al. The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J. Headache Pain. 16, 515 (2015).
Zebenigus, M., Tekle-Haimanot, R., Worku, D. K., Thomas, H. & Steiner, T. J. The prevalence of primary headache disorders in Ethiopia. J. Headache Pain. 17, 110 (2016).
Lipton, R. B. et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 58, 885–894 (2002).
Henry, P. et al. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia 12, 229–237 (1992).
Henry, P. et al. Prevalence and clinical characteristics of migraine in France. Neurology 59, 232–237 (2002).
Linde, M., Stovner, L. J., Zwart, J. A. & Hagen, K. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia 31, 585–596 (2011).
Hagen, K., Stovner, L. J. & Zwart, J. A. Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trondelag health surveys. J. Headache Pain. 21, 24 (2020).
Lyngberg, A. C., Rasmussen, B. K., Jorgensen, T. & Jensen, R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur. J. Epidemiol. 20, 243–249 (2005).
Fernandez-de-las-Penas, C. et al. Has the prevalence of migraine changed over the last decade (2003–2012)? A Spanish population-based survey. PLoS ONE 9, e110530 (2014).
Le, H., Tfelt-Hansen, P., Skytthe, A., Kyvik, K. O. & Olesen, J. Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study. BMJ Open 2, e000962 (2012).
Sillanpaa, M. & Anttila, P. Increasing prevalence of headache in 7-year-old schoolchildren. Headache 36, 466–470 (1996).
Wang, S. J., Fuh, J. L., Juang, K. D. & Lu, S. R. Rising prevalence of migraine in Taiwanese adolescents aged 13–15 years. Cephalalgia 25, 433–438 (2005).
Steiner, T. J. et al. Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description. J. Headache Pain. 22, 78 (2021).
Tinelli, M. et al. Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J. Headache Pain. 22, 90 (2021).
Tinelli, M. et al. Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology. J. Headache Pain. 22, 99 (2021).
Zebenigus, M., Tekle-Haimanot, R., Worku, D. K., Thomas, H. & Steiner, T. J. The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey. J. Headache Pain. 18, 58 (2017).
Mbewe, E., Zairemthiama, P., Paul, R., Birbeck, G. L. & Steiner, T. J. The burden of primary headache disorders in Zambia: national estimates from a population-based door-to-door survey. J. Headache Pain. 16, 36 (2015).
Rastenytė, D. et al. Prevalence and burden of headache disorders in Lithuania and their public-health and policy implications: a population-based study within the Eurolight Project. J. Headache Pain. 18, 53 (2017).
Ayzenberg, I. et al. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur. J. Neurol. 21, 758–765 (2014).
Steiner, T. J. et al. The impact of headache in Europe: principal results of the Eurolight project. J. Headache Pain. 15, 31 (2014).
Allena, M. et al. Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight Project. J. Headache Pain. 16, 100 (2015).
Rao, G. N., Kulkarni, G. B., Gururaj, G., Stovner, L. J. & Steiner, T. J. The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State. J. Headache Pain. 16, 94 (2015).
Manandhar, K., Risal, A., Linde, M. & Steiner, T. J. The burden of headache disorders in Nepal: estimates from a population-based survey. J. Headache Pain. 17, 3 (2016).
Yu, S. et al. Headache yesterday in China: a new approach to estimating the burden of headache, applied in a general-population survey in China. Cephalalgia 33, 1211–1217 (2013).
Genc, D. et al. The burden attributable to headache disorders in children and adolescents in Lithuania: estimates from a national schools-based study. J. Headache Pain. 22, 24 (2021).
Steiner, T. J., Linde, M. & Schnell-Inderst, P. A universal outcome measure for headache treatments, care-delivery systems and economic analysis. J. Headache Pain. 22, 63 (2021).
Salomon, J. A. et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380, 2129–2143 (2012).
Childs, A. J. & Sweetnam, M. T. A study of 104 cases of migraine. Br. J. Ind. Med. 18, 234–236 (1961).
Bille, B. Migraine in school children. A study of the incidence and short-term prognosis, and a clinical, psychological and electroencephalographic comparison between children with migraine and matched controls. Acta Paediatr. 51, 1–151 (1962).
Waters, W. E. & O’Connor, P. J. Prevalence of migraine. J. Neurol. Neurosurg. Psychiatry 34, 613–616 (1971).
Steiner, T. J. Lifting The Burden: the global campaign against headache. Lancet Neurol. 3, 204–205 (2004).
Author information
Authors and Affiliations
Contributions
The authors contributed equally to this manuscript.
Corresponding author
Ethics declarations
Competing interests
Both authors are directors and trustees of Lifting The Burden. T.J.S. has no other competing interests. L.J.S. has received lecture fees and research contributions from Allergan, Lilly, Lundbeck, Novartis and Teva during the last 3 years.
Peer review
Peer review information
Nature Reviews Neurology thanks Min Kyung Chu, Matilde Leonardi, Jes Olesen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
GBD interactive website: https://vizhub.healthdata.org/gbd-compare/
Glossary
- Caseness
-
Whether or not an individual has the condition of interest.
- Cluster-sampling
-
A method of probability sampling in which a population is divided into smaller groups, or clusters. Clusters are then randomly selected to form a sample.
- Retropolations
-
Backward extrapolations.
- Secular trends
-
Long-term trends.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Steiner, T.J., Stovner, L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19, 109–117 (2023). https://doi.org/10.1038/s41582-022-00763-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-022-00763-1
This article is cited by
-
The effect of selenium supplementation on oxidative stress, clinical symptoms and mental health status in patients with migraine: a study protocol for a double-blinded randomized clinical trial
Trials (2024)
-
The effectiveness of agomelatine on headache severity and frequency in episodic migraine without aura; a parallel randomized controlled trial study
BMC Neurology (2024)
-
The prevalence and demographic associations of headache in the adult population of Peru: a national cross-sectional population-based study
The Journal of Headache and Pain (2024)
-
The prevalence of headache in the adult population of Morocco: a cross-sectional population-based study
The Journal of Headache and Pain (2024)
-
The burden of headache disorders in North India: methodology, and validation of a Hindi version of the HARDSHIP questionnaire, for a community-based survey in Delhi and national capital territory region
The Journal of Headache and Pain (2024)